← Back to catalogue

Restylane Lyft

FDA UDI

Class III (US FDA UDI)

by Acre Pharma Limited

Identity

Trade Name
Restylane Lyft FDA UDI
Generic Name
Dermal tissue reconstructive material, animal-derived FDA UDI
Model / Reference
N/A FDA UDI

Identifiers

Primary DI / UDI-DI
05060604130072 FDA UDI
FDA Product Code
LMH FDA UDI
GMDN Term
Dermal tissue reconstructive material, animal-derived FDA UDI

Classification

Device Class
Class III FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

Yes

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Dermal tissue reconstructive material, animal-derived

Restylane Lyft by Acre Pharma Limited — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Dermal tissue reconstructive material, animal-derived.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Acre Pharma Limited

Sources (1)

  • FDA UDI d62699b7-972e-4d0a-88f2-8022e7290852 33 fields · synced Jun 1, 2026